How do you protect investor capital in a default cycle?
Investor protection starts with structure and reporting: defined exposure, clear eligibility criteria, performance triggers, market-level analysis, repayment data and the ability to slow or pause volume when a vintage drifts. Deal-specific protections are negotiated and documented under NDA.
What's the typical investor tenor and exit?
Tenor depends on instrument, market, currency, product type and legal structure. Senior debt, equity participation and risk-share are not the same risk. Qualified investors receive indicative term ranges, repayment logic and exit assumptions after the initial screening call.
How do you handle currency risk?
Currency risk is reviewed market by market. The preference is to align exposure with local receivables and repayment rails where possible; any mismatch must be priced, hedged or otherwise disclosed in the relevant materials.
What happens if a market hits a regulatory change?
Regulatory change is treated as a product and operating risk, not a legal footnote. WIAM evaluates licensing or partner structure, data protection, customer communication, disclosure rules, collection conduct and technology changes before scaling any market.
How do investors get visibility into portfolio performance?
Qualified investors can receive monthly or quarterly reporting packages depending on the instrument: originations, repayments, arrears movement, vintage tables, model commentary, fraud indicators, servicing notes and market updates.
What's the minimum ticket?
Minimums are handled case by case because instrument type, jurisdiction, tenor, currency and reporting requirements materially affect the economics. WIAM prioritizes strategic and institutional partners who can understand consumer-credit risk.
How are returns calculated and paid?
Return mechanics depend on the structure. Equity, senior debt and risk-share each carry different settlement periods, fees, reserves and legal documentation. Binding economics are discussed only after the investor has reviewed the relevant materials.
Are you regulated?
Regulatory treatment is market-specific. WIAM does not present research markets as live operations. Qualified partners receive the relevant legal, licensing, partner-structure and compliance context under NDA.